Al-Chalabi, A., Shaw, P., Leigh, P. N., van den Berg, L., Hardiman, O., Ludolph, A., . . . Kuoppamäki, M. (2019). Oral levosimendan in amyotrophic lateral sclerosis: A phase II multicentre, randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry.
Styl ChicagoAl-Chalabi, Ammar, Pamela Shaw, P Nigel Leigh, Leonard van den Berg, Orla Hardiman, Albert Ludolph, Valtteri V. Aho, Toni Sarapohja, a Mikko Kuoppamäki. "Oral Levosimendan in Amyotrophic Lateral Sclerosis: A Phase II Multicentre, Randomised, Double-blind, Placebo-controlled Trial." J Neurol Neurosurg Psychiatry 2019.
Citace podle MLAAl-Chalabi, Ammar, et al. "Oral Levosimendan in Amyotrophic Lateral Sclerosis: A Phase II Multicentre, Randomised, Double-blind, Placebo-controlled Trial." J Neurol Neurosurg Psychiatry 2019.